TMU-August 1995
Xarelto (rivaroxaban) Prescriber Guide
Evolving Practice: Role of Anti-Factor Xa Testing in Modern Anticoagulation
Do Novel Anticoagulants Affect the PT/INR? The Cases of XARELTO (rivaroxaban) and PRADAXA (dabigatran) | Leaders in Pharmaceutical Business Intelligence (LPBI) Group
Reversal of Novel Oral Anticoagulants
Treatment Considerations | XARELTO® (rivaroxaban) HCP
Canada Cloud Pharmacy | Trusted Canadian Online Pharmacy
Anticoagulant specific factor inhibition. #anticoagulation ... | GrepMed
Do Novel Anticoagulants Affect the PT/INR? The Cases of XARELTO (rivaroxaban) and PRADAXA (dabigatran) | Leaders in Pharmaceutical Business Intelligence (LPBI) Group
Xarelto: Package Insert - Drugs.com
Rivaroxaban: a fully-subsidised oral anticoagulant
Standard coagulation assays alone are not sufficient to exclude surgically relevant rivaroxaban plasma concentrations | Perioperative Medicine | Full Text
Practical Management of Patients receiving Rivaroxaban
Evaluation of the Efficacy and Safety of Rivaroxaban Using a Computer Model for Blood Coagulation | PLOS ONE
Slightly elevated international normalized ratio predicts bleeding episodes in patients treated with direct oral anticoagulants - Priya Bhardwaj, Louise Breum Petersen, Tomas Sorm Binko, Jan Roland Petersen, Gitte Gleerup Fornitz, 2020
How to Switch From Warfarin to Xarelto - GoodRx
Frontiers | Computational investigation of potential dosing schedules for a switch of medication from warfarin to rivaroxaban—an oral, direct Factor Xa inhibitor
Xarelto® (rivaroxaban) Prescriber Guide Version 5
A) Switching from VKAs to rivaroxaban. (B) Switching from rivaroxaban... | Download Scientific Diagram
Xarelto (rivaroxaban) Prescriber Guide
CorConsult Rx - #Repost @ambcarerx ・・・ Oral Anticoagulants have many chronic indications, most commonly VTE treatment/prophylaxis, atrial fibrillation, and valvular heart disease. VTE & AF can both be treated with either warfarin
POTD: COAGs and NOACs — Maimonides Emergency Medicine Residency
Xarelto® (rivaroxaban) - Recall, Warnings & Lawsuit Information
Pediatric VTE | XARELTO® (rivaroxaban) HCP
Xarelto Litigation | Pill Dosage Should Have Been Individualized
Practical Management of Patients receiving Rivaroxaban
Slightly elevated international normalized ratio predicts bleeding episodes in patients treated with direct oral anticoagulants - Priya Bhardwaj, Louise Breum Petersen, Tomas Sorm Binko, Jan Roland Petersen, Gitte Gleerup Fornitz, 2020
